| Angela Elizabeth Sandre, DO | |
|
411 Laurel St Ste A300, Des Moines, IA 50314-3030 | |
| (515) 282-2921 | |
| (515) 643-8819 |
| Full Name | Angela Elizabeth Sandre |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 24 Years |
| Location | 411 Laurel St Ste A300, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588601157 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 3406 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| H C I Care Services | Des moines, IA | Hospice |
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Mercyone Centerville Medical Center | Centerville, IA | Hospital |
| Unitypoint Health - Des Moines Iowa Methodist Medi | Des moines, IA | Hospital |
| Dallas County Hospital | Perry, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mission Cancer And Blood, Pllc | 1254224876 | 62 |
News Archive
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States
Researchers at the Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona (IBB-UAB), in collaboration with the biopharmaceutical company SOM Biotech, located in the Barcelona Science Park (PCB), have published, in Nature Communications, the results of a drug repositioning study in which they describe a powerful drug, SOM0226 (tolcapone) that could significantly improve the pharmacological treatment of familial transthyretin amyloidosis (ATTR).
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
GfK Asia releases its Pan Asia optical retailers and consumers preference survey information in line with the 17th Hong Kong Optical Fair, hosted by Hong Kong Trade Development Council. The five key regions surveyed in October 2009 include China, Hong Kong, Korea, Singapore and Malaysia. The survey shows that 70% of optical retailers indicate business will be better or the same in 2010.
› Verified 4 days ago
| Entity Name | Mission Cancer And Blood, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639135585 PECOS PAC ID: 1254224876 Enrollment ID: O20040205001270 |
News Archive
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States
Researchers at the Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona (IBB-UAB), in collaboration with the biopharmaceutical company SOM Biotech, located in the Barcelona Science Park (PCB), have published, in Nature Communications, the results of a drug repositioning study in which they describe a powerful drug, SOM0226 (tolcapone) that could significantly improve the pharmacological treatment of familial transthyretin amyloidosis (ATTR).
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
GfK Asia releases its Pan Asia optical retailers and consumers preference survey information in line with the 17th Hong Kong Optical Fair, hosted by Hong Kong Trade Development Council. The five key regions surveyed in October 2009 include China, Hong Kong, Korea, Singapore and Malaysia. The survey shows that 70% of optical retailers indicate business will be better or the same in 2010.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela Elizabeth Sandre, DO 411 Laurel St Ste A300, Des Moines, IA 50314-3030 Ph: (515) 282-2921 | Angela Elizabeth Sandre, DO 411 Laurel St Ste A300, Des Moines, IA 50314-3030 Ph: (515) 282-2921 |
News Archive
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States
Researchers at the Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona (IBB-UAB), in collaboration with the biopharmaceutical company SOM Biotech, located in the Barcelona Science Park (PCB), have published, in Nature Communications, the results of a drug repositioning study in which they describe a powerful drug, SOM0226 (tolcapone) that could significantly improve the pharmacological treatment of familial transthyretin amyloidosis (ATTR).
Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.
GfK Asia releases its Pan Asia optical retailers and consumers preference survey information in line with the 17th Hong Kong Optical Fair, hosted by Hong Kong Trade Development Council. The five key regions surveyed in October 2009 include China, Hong Kong, Korea, Singapore and Malaysia. The survey shows that 70% of optical retailers indicate business will be better or the same in 2010.
› Verified 4 days ago
Dr. Joshua C Lukenbill, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant Street, Suite 100, Des Moines, IA 50309 Phone: 515-282-2921 Fax: 515-282-1035 | |
Dr. Akshay Mahesh Khatri, M.B.B.S., MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant St Ste 300, Des Moines, IA 50309 Phone: 515-241-4200 Fax: 515-241-4048 | |
Dr. Ravinder K Dervesh, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St Ste 1225, Des Moines, IA 50314 Phone: 515-633-3770 Fax: 515-288-6713 | |
Mr. David Augusto Terrero Salcedo, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant St Ste 300, Des Moines, IA 50309 Phone: 515-241-4200 Fax: 515-241-4048 | |
Tyler Mumm, DO Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-2261 Fax: 515-643-5802 | |
Bilal Hasan Baig, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6636 Fax: 515-241-4080 | |
Dr. Sean D Cunningham, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St, Ste 206, Des Moines, IA 50309 Phone: 515-875-9092 Fax: 515-875-9828 |